Sisätautien yksikkö
Department of Internal Medicine

Julkaisut 2006
Publications 2006

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.

1 Andrulionyté L et al. Single nucleotide polymorphisms of the HNF4alfa gene are associated with the conversion to type 2 diabetes mellitus: the STOP-NIDDM trial.
2 Andrulionyté L et al. Single nucleotide polymorphisms of PPARD in combination with the Gly482Ser substitution of PGC-1A and the Pro12Ala substitution of PPARG2 predict the conversion from impaired glucose tolerance to type 2 diabetes: the STOP-NIDDM Trial.
3 Antman EM et al. Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction.
4 Fagerudd J et al. Low birth weight does not increase the risk of nephropathy in Finnish type 1 diabetic patients.
5 González-Sánchez JL et al. Interaction of the - 308G/A promoter polymorphism of the tumor necrosis factor-alfa gene with single-nucleotide polymorphism 45 of the adiponectin gene: effect on serum adiponectin concentrations in a Spanish population.
6 Hallikainen M et al. Endothelial function in hypercholesterolemic subjects: Effects of plant stanol and sterol esters.
7 Hallikainen M et al. Interaction between cholesterol and glucose metabolism during dietary carbohydrate midification in subjects with the metabolic syndrome 1-3.
8 Halonen J et al. Intravenous administration of metoprolol is more effective than oral administration in the prevention of atrial fibrallation after cardiac surgery.
9 Halonen P et al. Lääkäripalvelujen laatu väestön arvioimana.
10 Hammarstedt A et al. Visfatin is an adipokine, but it is not regulated by Thiazolidinediones.
11 Hartikainen J et al. Lääkärien terapeuttiset asenteet sydän- ja verisuonitautien vaaratekijöiden, erityisesti ylipainon ja tupakoinnin hoitoon.
12 Heiskanen TH et al. Metabolic syndrome and depression: a cross-sectional analysis.
13 Jantunen E. Autologous stem cell transplantation beyond 60 years of age.
14 Jantunen E et al. Early treatment-related mortality in adult autologous stem cell transplant recipients: a nation-wide survey of 1482 transplanted patients.
15 Jantunen E et al. Autologous stem cell transplantation in patients with chronic lymphocytic leukaemia: the Finnish experience.
16 Jantunen E et al. High-dose melphalan (200 mg/m2) supported by autologous stem cell transplantation is safe and effective in elderly (>or=65 years) myeloma patients: comparison with younger patients on the same protocol.
17 Jantunen E et al. Anagrelidi krooniseen myeloproliferatiiviseen tautiin liittyvän trombosytoosin hoidossa.
18 Julkunen R. Hiivasyndrooma - tarua vai totta?
19 Juutilainen A et al. Proteinuria and metabolic syndrome as predictors of cardiovascular death in non-diabetic and type 2 diabetic men and women.
20 Kaipiainen-Seppänen O, Kautiainen H. Declining trend in the incidence of rheumatoid factor-positive rheumatoid arthritis in Finland 1980-2000.
21 Karinen H et al. Gene dose effect of the DQB1*0201 allele contributes to severity of coeliac disease.
22 Karinen H et al. HLA genotyping is useful in the evaluation of the risk for coelic disease in the 1st-degree relatives of patients with coeliac disease.
23 Kauppinen-Mäkelin R et al. Quality of life in treated patients with acromegaly.
24 Keech A et al. Correction to the FIELD study report.
25 Kivelä A, Hartikainen J. Restenosis related to percutaneous coronary intervention has been solved?
26 Koivisto AM et al. Association analysis of peroxisome proliferator-activated receptor gamma polymorphisms and late onset Alzhimer´s disease in the Finnish population.
27 Kopelman P et al. Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients.
28 Koskela H, Kaipiainen-Seppänen O. Amyopaattiseen dermatomyosiittiin liittyvä interstitiaalinen keuhkosairaus .
29 Kuittinen T. Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma. Progenitor Cell Mobilisation, Toxicity of High-dose Therapy, and Progressive Disease After Transplantation.
30 Kuittinen T et al. Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
31 Kurl S et al. Metabolic syndrome and the risk of stroke in middle-aged men.
32 Kuukasjärvi P et al. Overview of systematic reviews on invasive treatment of stable coronary artery disease.
33 Kärkkäinen S et al. Novel mutations in the lamin A/C gene in heart transplant recipients with end stage dilated cardiomyopathy.
34 Laakso M. Metformiini: vanha lääke, uusi vaikutusmekanismi.
35 Laakso M. Mutations in the PPARgamma gene relevant for diabetes and the metabolic syndrome.
36 Laakso M, Kovanen PT. Metabolic syndrome: To be or not to be?
37 Laaksonen DE, Niskanen L. Metabolinen oireyhtymä ja diabetes - lihavuuden hoidon ykköskohteet.
38 Lagouge M et al. Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha.
39 Laukkanen O. Genes Regulating Insulin Secretion and Insulin Signaling as Candidate Genes for Type 2 Diabetes in Subjects with Impaired Glucose Tolerance.
40 Lumiaho A, Laakso M. Autosomissa vallitsevasti periytyvä munuaisten monirakkulatauti.
41 Lundell L et al. Changes of gastric mucosal architecture during long.-term omeprazole therapy: results of a randomized clinical trial.
42 Mager U et al. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of type 2 diabetes in subjects with impaired glucose tolerance in the Finnish diabetes prevention study.
43 Majamaa-Voltti KAM et al. A 3-year clinical follow-up of adult patients with 3243A>G in mitochondrial DNA.
44 Mousavinasab F et al. Common polymorphisms (single-nucleotide polymorphisms SNP+45 and SNP+276) of the adiponectin gene regulate serum adiponectin concentrations and blood pressure in young Finnish men.
45 Mousavinasab F et al. The pro12Ala polymorphism of the PPAR gamma 2 gene influences sex hormone binding globulin level and its relationship to the development of the metabolic syndrome in young Finnish men.
46 Möttönen T et al. Efficacy of combination therapy in rheumatoid arthritis: Comment on the review by Smolen et al.
47 Niiranen K et al. Mice with targeted disruption of spermidine/spermine N1-acetyltransferese gene maintain nearly normal tissue polyamine homeostasis but show signs of insulin resistance upon aging.
48 Niskanen L et al. Serum uric acid as a harbinder of metabolic outcome in subjects with impaired glucose tolerance.
49 Nordström DC et al. Classic disease modifying anti-rheumatic drugs (DMARDs) in combination with infliximab. The Finnish experience .
50 Otonkoski T et al. Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.
51 Pajala M et al. A prospective 1-years follow-up study in patients with functional or organic dyspepsia: changes in gastrointestinal symptoms, mental distress and fear of serious illness.
52 Peltola P et al. Visceral obesity is associated with high levels of serum squalene.
53 Pihlajamäki J et al. Common polymorphisms of calpain-10 are associated with abdominal obesity in subjects at high risk of type 2 diabetes.
54 Poutanen K et al. The role of carbohydrates in the prevention and management of type 2 diabetes.
55 Poutanen T et al. Diastolic dysfunction without left ventricular hypertrophy is an early finding in children with hypertrophic cardiomyopathy-causing mutations in the beeta-myosin heavy chain, alfa-tropomyosin, and myosin-binding protein C genes.
56 Puolakka K et al. Monetary value of lost productivity over a five year follow up in early rheumatoid arthritis estimated on the basis of official register data on patients' sickness absence and gross income: experience from the FIN-RACo trial.
57 Ristikankare M et al. Sedation, topical pharyngeal anesthesia and cardiorespiratory safety during gastroscopy.
58 Roy H et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits.
59 Roy H et al. VEGF-A, VEGF-D, VEGF receptor-1, VEGF receptor-2, NF-kappaB, and RAGE in atherosclerotic lesions of diabetic Watanabe heritable hyperlipidemic rabbits [FJ Express Full-Length Article].
60 Ruotsalainen E et al. Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects.
61 Saarela T et al. Plasma cell membrane glycoprotein-1 K121Qmpolymorphism in preeclampsia.
62 Saarela T et al. Adiponectin gene haplotype is associated with preeclampsia.
63 Saarela T et al. Polymorphisms of interleukin-6, hepatic lipase and calpain-10 genes, and preeclampsia.
64 Salmenniemi U. Metabolic and Genetic Abnormalities Clustering with Intra-abdominal Obesity.
65 Salomaa V et al. The effect of correcting for troponins on trends in coronary heart disease events in Finland during 1993-2002: the FINAMI study.
66 Scheen AJ et al. Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.
67 Scholte op Reimer W et al. Smoking behaviour in European patients with established coronary heart disease.
68 Siiriä-Waris K et al. Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure.
69 Siitonen N et al. Association of sequence variations in the gene encoding adoponectin receptor 1 (ADIPOR1) with body size and insulin levels. The Finnish diabetes prevention study.
70 Sipola P et al. Myocardial late gadolinium enhancement is associated with raised serum amino-terminal propeptide of type III collagen concentrations in patients with hypertrophic cardiomyopathy attributable to the Asp175Asn mutation in the alpha tropomyosin gene:
71 Smith U et al. Pathogenesis and treatment of diabetic vascular disease - illustrated by two cases.
72 Soinio M et al. High-sensitivity C-reactive protein and coronary heart disease mortality in patients with type 2 diabetes: a 7-year follow-up study.
73 The ACTIVE Writing Group on behalf of the ACTIVE Investigators. Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of vascular events (ACTIVE W): a randomised controlled trial .
74 The DREAM Trial Investigators. Effect of ramipril on the incidence of diabetes.
75 The DREAM Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial.
76 van Veldhuisen DJ et al. Presence and development of atrial fibrillation in chronic heart failure Experiences from the Merit-HF Study.
77 Vanhanen M et al. Association of metabolic syndrome with Alzheimer disease: a population-based study.
78 Zacharova J. Insulin-Sensitizing Genes and Risk of Type 2 Diabetes. Studies on the PGC-l alpha, PPAR gamma, Adiponectin, Leptin Receptor and Hepatic Lipase Genes.

Sisätautien yksikkö Department of Internal Medicine
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008